RJRaymond James Financial ownership: holders and insider trading
$168.64+0.81%Close 13 Nov 2026 · Market value $32.15B
As filed, its directors and officers own 0.6% of the shares (proxy statement, 7 Jan 2026); 899 institutional managers reported holding 79.0% at 30 Jun 2026. Over the last twelve months, insiders sold $30.39M of shares on the open market, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Vanguard | Institution | 21.9M | 11.38%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock | Institution | 14.3M | 7.47%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 13.1M | 6.62% | Schedule 13G | 31 Mar 2026 |
|---|
| Wellington Management | Institution | 9.4M | 4.92%* | Form 13F | 30 Jun 2026 |
|---|
| Primecap Management Co | Institution | 9.2M | 4.81%* | Form 13F | 30 Jun 2026 |
|---|
| State Street | Institution | 7.9M | 4.11%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 4.6M | 2.42%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 4.4M | 2.29%* | Form 13F | 30 Jun 2026 |
|---|
| Harris Associates L P | Institution | 3.7M | 1.92%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 3.1M | 1.61%* | Form 13F | 30 Jun 2026 |
|---|
| JPMorgan Chase | Institution | 2.7M | 1.41%* | Form 13F | 30 Jun 2026 |
|---|
| Dimensional Fund Advisors | Institution | 2.4M | 1.28%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 2.4M | 1.27%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 2.4M | 1.23%* | Form 13F | 30 Jun 2026 |
|---|
| Victory Capital Management Inc | Institution | 2.3M | 1.21%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 2.3M | 1.19%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 2.2M | 1.16%* | Form 13F | 30 Jun 2026 |
|---|
| Earnest Partners LLC | Institution | 2.2M | 1.15%* | Form 13F | 30 Jun 2026 |
|---|
| Goldman Sachs | Institution | 2.1M | 1.10%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 2.0M | 1.07%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Allaire Bella Loykhter · Chief Admin Officer | 28 Aug 2026 | Open-market sale | −7.5K | $177.60 | $1.33M |
|---|
| Elwyn Tashtego S · President, PCG | 28 Jul 2026 | Open-market sale | −10.0K | $176.06 | $1.76M |
|---|
| Raney Steven M · Executive Chair RJBank | 27 Jul 2026 | Open-market sale | −5.8K | $172.97 | $998.0K |
|---|
| Allaire Bella Loykhter · Chief Admin Officer | 19 Mar 2026 | Open-market sale | −29.6K | $142.34 | $4.21M |
|---|
| Aisenbrey Christopher S · Chief Human Resources Officer | 28 Feb 2026 | Option exercise | +600 | — | — |
|---|
| Aisenbrey Christopher S · Chief Human Resources Officer | 28 Feb 2026 | Shares withheld for tax | −132 | $153.08 | $20.21K |
|---|
| Seshadri Raj · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| MCDANIEL RAYMOND W · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| MCGEARY RODERICK C · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| Gates Anne · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| GARCIA ART A · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| Esty Benjamin · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| Mistarz Cecily · Director | 19 Feb 2026 | Option exercise | +250 | — | — |
|---|
| Mistarz Cecily · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| Mistarz Cecily · Director | 19 Feb 2026 | Option exercise | +1.3K | — | — |
|---|
| Mistarz Cecily · Director | 19 Feb 2026 | Option exercise | +250 | — | — |
|---|
| Edwards Jeffrey N · Director | 19 Feb 2026 | Option exercise | +1.3K | — | — |
|---|
| DEBEL MARLENE · Director | 19 Feb 2026 | Option exercise | +1.3K | — | — |
|---|
| Begor Mark W · Director | 19 Feb 2026 | Grant or award | +1.3K | — | — |
|---|
| Santelli Jonathan N · EVP, General Counsel | 4 Feb 2026 | Open-market sale | −4.5K | $170.46 | $767.1K |
|---|
| Santelli Jonathan N · EVP, Gen Counsel, Secy | 15 Dec 2025 | Shares withheld for tax | −1.3K | $163.85 | $210.4K |
|---|
| Santelli Jonathan N · EVP, Gen Counsel, Secy | 15 Dec 2025 | Option exercise | +2.7K | — | — |
|---|
| Santelli Jonathan N · EVP, Gen Counsel, Secy | 15 Dec 2025 | Option exercise | +1.6K | — | — |
|---|
| Santelli Jonathan N · EVP, Gen Counsel, Secy | 15 Dec 2025 | Shares withheld for tax | −647 | $163.85 | $106.0K |
|---|
| Santelli Jonathan N · EVP, Gen Counsel, Secy | 15 Dec 2025 | Shares withheld for tax | −837 | $163.85 | $137.1K |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
RJF in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.